A Safety and Efficacy Study for Tapentadol (CG5503) Extended Release for Patients With Painful Diabetic Peripheral Neuropathy

Clinical trial NCT00455520 · COMPLETED

Trial details

NCT number: NCT00455520
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetic Neuropathy

Start date: 2007-04-01
Primary completion: 2008-08-01
Enrollment: 395

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.